AXIN2 and gastric cancer: Previous research has shown that frameshift mutations in Wnt pathway regulators like AXIN2 and TCF7L2 are common in gastric cancers with high MSI, further linking Wnt pathway dysregulation to tumor progression (Kim et al., 2009).